Joanne (Juan) Wu, ScD

Associate Director
Pfizer

Poster(s):

• (005) Challenges, Lessons Learned and Implications for Improvement in Employing Drug Utilization Studies to Evaluate the Effectiveness of Additional Risk Minimization Measures (aRMMs)
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (336) Current Approaches in Post-Approval Vaccine Safety Studies Using Real-World Data: A Systematic Review of Published Literature
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (351) Preliminary Findings from a Feasibility and Capacity Assessment of Truveta® Studio using Flu Vaccine as Example: A Near Real-Time Electronic Health Records Database with Potential to Monitor Post-Approval Vaccine Safety
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST